Interestingly, Topotecan, a clinically used Top1 poison, can activate dendritic cells of tumour-bearing mice as exosomes released by the treated tumours are incorporated by dendritic cells, which then triggers the cGAS/STING signalling pathway [136]. The gene discussed is CGAS; the disease is neoplasm.